Lumeris Introduces Tom™, an AI-Powered Breakthrough to Transform Primary Care PressReach · Feb 19, 2025
Patented transdermal drug candidate from Vascarta may offer a convenient & cost-effective way to treat sickle cell disease PressReach · Feb 19, 2025
CKGSB and Johns Hopkins University Launch AI-Driven Healthcare Innovation Program PressReach · Feb 19, 2025
Newfound Circuit Better Explains How the Brain Recognizes What Is Familiar and Important PressReach · Feb 18, 2025
LoQus23 Therapeutics appoints Cyrus Mozayeni MD to Chair of the Board of Directors PressReach · Feb 18, 2025
Innovent Receives Second Fast Track Designation from the U.S. FDA for IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Squamous Non-Small Cell Lung Cancer PressReach · Feb 17, 2025
Certain Tumblers Pizza brand U Bake Pizzas recalled due to undeclared Mustard PressReach · Feb 17, 2025
Government of Canada takes further action to address fentanyl precursor chemicals PressReach · Feb 15, 2025
ASCO GU｜RemeGen Announced Highly Encouraging Data from the Phase II Clinical Trial Evaluating Disitamab Vedotin plus Immunotherapy as Perioperative Regimen for Bladder Cancer PressReach · Feb 15, 2025
